Quantitative HBsAg Testing
Role of Quantitative HBsAg Testing in Clinical Practice for People With CHB

Released: November 29, 2023

Activity

Progress
1
Course Completed

Should quantitative HBsAg testing be used routinely in clinical practice for patients living with chronic hepatitis B?

In this episode, Tatyana Kushner, MD, MSCE, discusses the role of quantitative hepatitis B surface antigen testing in people living with chronic hepatitis B, including:

  • Determination of inactive carrier status
  • Prediction of liver fibrosis/cirrhosis
  • Prediction of hepatocellular carcinoma development
  • Monitoring response to treatment, including future HBV treatments in the development pipeline
  • Prediction of HBsAg loss

Joining her for the panel discussion are Ira M. Jacobson, MD, and Paul Y. Kwo, MD.